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Abstract Objective To identify possible avenues of
sparing the internal mammary artery (IMA) for coronary
artery bypass grafting (CABG) in women undergoing
autologous breast reconstruction with deep inferior epi-
gastric artery perforator (DIEP) flaps. Background Optimal
autologous reconstruction of the breast and coronary artery
bypass grafting (CABG) are often mutually exclusive as
they both require utilisation of the IMA as the preferred
arterial conduit. Given the prevalence of both breast cancer
and coronary artery disease, this is an important issue for
women’s health as women with DIEP flap reconstructions
and women at increased risk of developing coronary artery
disease are potentially restricted from receiving this
reconstructive option should the other condition arise.
Methods The largest clinical and cadaveric anatomical
study (n = 315) to date was performed, investigating four
solutions to this predicament by correlating the precise
requirements of breast reconstruction and CABG against
the anatomical features of the in situ IMAs. This infor-
mation was supplemented by a thorough literature review.
Results Minimum lengths of the left and right IMA needed
for grafting to the left-anterior descending artery are 160.08
and 177.80 mm, respectively. Based on anatomical find-
ings, the suitable options for anastomosis to each intercos-
tals space are offered. In addition, 87–91% of patients have
IMA perforator vessels to which DIEP flaps can be anas-
tomosed in the first- and second-intercostal spaces. Con-
clusion We outline five methods of preserving the IMA for
future CABG: (1) lowering the level of DIEP flaps to the
fourth- and fifth-intercostals spaces, (2) using the DIEP
pedicle as an intermediary for CABG, (3) using IMA per-
forators to spare the IMA proper, (4) using and end-to-side
anastomosis between the DIEP pedicle and IMA and (5)
anastomosis of DIEP flaps using retrograde flow from the
distal IMA. With careful patient selection, we hypothesize
using the IMA for autologous breast reconstruction need not
be an absolute contraindication for future CABG.
Keywords IMA  Internal mammary artery  Internal
thoracic artery  CABG  Coronary artery bypass grafting 
Breast cancer  Breast reconstruction  DIEP  Deep inferior
epigastric artery perforator flap  Recipient vessels 
Anatomical study  CTA  Computer tomographic
angiography
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Introduction
Breast cancer and coronary artery disease are two leading
causes of morbidity and mortality in women. Fortunately,
they are amenable to surgical intervention in the forms
of mastectomy with subsequent breast reconstruction and
coronary artery bypass grafting (CABG). However, the
optimal techniques for autologous breast reconstruction
[1–8], the deep inferior epigastric artery perforator (DIEP)
flap using the internal mammary artery as the recipient vessel
and the IMA-based CABG, are mutually exclusive as they
both require use of the IMAs as an arterial conduit [9–15]. In
theory, this may preclude women with pre-existing DIEP
reconstructions from receiving CABGs (with proven
survival benefit) and women at increased risk of developing
coronary artery disease from receiving what many surgeons
consider to be the optimal autologous breast reconstruction
post-mastectomy. In the light of the prevalence of both
conditions, we believe investigating potential strategies to
overcome this problem is of importance to women’s health.
Background
Breast cancer
Breast cancer is the leading cause of cancer in women
[16–19]. Each year, more than 690,000 women are diag-
nosed with breast cancers in high-income countries at a rate
of 83.2 new breast cancers per 100,000 population [17]. Of
the women who elect for treatment, 44.3% receive mastec-
tomy [20]. In 2010, 61.5 mastectomies were performed
per 100,000 people in countries of the Organisation for
Economic Co-operation and Development (OECD), making
it one of the most common surgical procedures in women of
the developed world (Table 1) [18]. Breast reconstructions
Table 1 The rates of breast
cancer, mastectomy and
coronary artery bypass graft
procedures performed per
100,000 population in the top 25
countries of the Organisation for
Economic Co-operation and
Development (OECD) in 2010
Country Breast
cancer [17]
Country Mastectomy
[18]
Country CABG
[18]
Belgium 109.19 Finland 89.0 Germany 131.8
Denmark 101.12 Belgium 87.0 Belgium 131.4
France 99.74 Netherlands 84.0 United States (2006) 84.5
The Netherlands 98.46 Denmark 83.0 Norway (2006) 81.0
Israel 96.77 Sweden 81.0 Denmark 80.5
Iceland 95.52 Korea 72.0 New Zealand 77.5
Ireland 93.94 Australia 71.0 Australia 71.8
Switzerland 89.38 Germany 70.0 Italy 70.7
New Zealand 89.37 Norway 70.0 Canada 68.9
United Kingdom 89.13 Luxembourg 68.0 Slovenia 62.8
Finland 86.31 United Kingdom 68.0 Czech Republic 62.4
Italy 86.29 France 61.0 Luxembourg 61.3
Australia 84.75 Switzerland 59.0 Iceland 59.7
Canada 83.17 Canada 54.0 Netherlands 58.2
Luxembourg 82.35 Austria 53.0 Finland 57.7
Germany 81.76 Italy 53.0 Israel 56.5
Sweden 79.40 New Zealand 51.0 Sweden 56.4
United States 75.99 Portugal 51.0 Poland 52.6
Norway 73.50 Israel 48.0 Austria 51.6
Czech Republic 70.85 Slovenia 46.0 United Kingdom 45.7
Slovenia 64.87 Iceland 45.0 Portugal 43.0
Croatia 63.99 Ireland 45.0 Ireland 40.5
Austria 62.13 Spain 45.0 Hungary 36.3
Spain 61.01 Hungary 43.0 France 30.9
Portugal 60.02 United States (2006) 40.0 Switzerland 30.8
OECD average 83.2 OECD average 61.5 OECD average 64.2
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are often necessary to remodel the defect and restore quality
of life. In 2009, more than 86,000 breast reconstructions
were performed in the United States alone, a statistic that has
exhibited a distinct upwards trend [21]. Currently, autolo-
gous tissue is the reconstructive option in suitable patients, is
with autologous tissue. The DIEP flap is widely believed to
yield excellent aesthetic outcomes with minimal donor site
morbidity. Although the American Society of plastic sur-
geons (ASPS) procedural statistics in 2010 shows that
implant-based breast reconstruction remains the most prac-
ticed form of breast reconstruction in the US (77%), with
DIEP flap reconstruction being the third most frequent
reconstruction (5.5%) behind latissimus flap reconstructions
(6.8%) [21], this is not because implant reconstructions
produce the best results, it is because of financial pressures
imposed by health insurance providers as microsurgical
procedures are time- and cost-intensive [22]. There is some
evidence that this may change in the future as experienced
microsurgeons argue that the relative increase in cost
is worthwhile when considering superior outcomes [23]
(see Fig. 1). DIEP flaps in many surgeons hands are
anastomosed to the IMA, often at the second- or third-
intercostals space (ICS), leaving insufficient length for
subsequent CABG. This is a particular concern in the setting
of bilateral mastectomies as both IMAs are used in the
reconstruction. Bilateral procedures currently constitute
around 10% of breast cancer operations and are becoming
increasingly frequent with the greater use of BRCA gene
testing and breast MRI [24–29]. Numerous studies have
reported an increasing trend towards IMA-based breast
reconstructions during the past 10–15 years (see Table 2)
[13, 14, 30–33].
Coronary artery disease
Heart disease is the biggest cause of mortality in women
worldwide. According to the World Health Organisation,
746,208 women died from ischemic events in 2008 in high-
income countries and this figure is projected to increase to
more than 936,000 women by 2030 [16].
The standard interventions for myocardial revascularisa-
tion are the CABG and percutaneous coronary intervention.
TRAM
Good volume [130]
Reliable blood supply [130]
Free TRAM flaps can create reconstructions that are as aesthetically pleasing
as DIEP flaps [131]
Greater abdominal wall morbidity than DIEP flaps resulting in hernia (2.6%)
or abdominal bulge (3.8%), especially in obese patients [129-34]
Decreased abdominal wall strength [129, 121]
Common methods of breast reconstruction post-mastectomy
Latissimus Dorsi flap
Robust blood supply [130, 131]
Good salvage option for re-operations [130, 131]
A readily available option for almost all patients [131]
Limited volume compared to DIEP and TRAM flaps [129-31]
Superior inferior epigastric artery (SIEA) flap
Minimally impact on abdominal wall function as fascia is no disrupted [130, 131]
Limited volume [130, 131]
Tenuous blood supply [130]
Higher rates of flap loss (2.9%) and re-operation (17.4%) [136]
Not suitable for women with inadequate abdominal adiposity [132]
Two-stage reconstruction (expander plus implant)
Requires less skin than single-stage reconstructions [129]
Multiple consultations required over several months [129, 130]
Tissue expanders require muscle coverage to prevent extrusion and 
to achieve adequate bulk [129, 130]
Additional procedure required to replace expander with implant [130]
Non-autologous (Implant-based)
Technically easier procedure with shorter operating time [129]
Lower initial costs than autologous methods ($15,497) [129, 133]
Less invasive and no donor site complications [129, 130]
May require revision surgery to achieve optimal aesthetic outcome [129,130]
The need for subsequent procedures substantially increases overall cost 
compared to autologous methods and the initial cost savings may be lost [129]
Complications include haematoma, infection, extrusion and capsular 
contracture, leak and rupture [129-32]
Appearance is less natural than autologous reconstructions. Breast asymmetry 
often requires modification procedure to be performed on the contralateral 
breast [129, 130]
Implants will eventually leak, thus one or more implant exchanges may be 
required in a lifetime [130]
Risk of complications is significantly increased by radiation [131]
Single-stage reconstruction
One stage procedure [129]
Requires preservation of a sufficient amount of healthy skin at 
mastectomy site [129]
Size of reconstructed breast is limited [129]
Unsuitable for women with larger breasts [130]
DIEP
Aesthetically superior contours [129]
Minimal donor site morbidity [129-32]
Longer lasting reconstruction at reasonable expense [23]
Technically difficult to perform [129, 115]
Increased risk of microvascular complications [129, 130]
Not suitable for women with inadequate abdominal adiposity [115]
Autologous (Tissue-based)
Softer, more natural outcome [129, 130]
Greater volume available for reconstruction [129]
Concomitant abdominoplasty [130]
Minimal ongoing long-term costs (unlike implants) [133]
Less affected by radiation [131]
Technically more demanding [129]
Longer operating time and recovery [129]
Creates secondary defect at donor site [129,130]
Higher initial costs than implant based reconstructions $19,607 [133]
Fig. 1 Summary of the advantages and disadvantages of the most
common methods of post-mastectomy breast reconstruction. Notably,
the deep inferior epigastric artery perforator flaps deliver more
superior aesthetic appearance and carry a lower risk of donor site
morbidity than alternative options available
Breast Cancer Res Treat (2012) 134:181–198 183
123
T
a
b
le
2
C
o
m
p
ar
is
o
n
o
f
th
e
ad
v
an
ta
g
es
an
d
d
is
ad
v
an
ta
g
es
o
f
th
e
co
m
m
o
n
re
ci
p
ie
n
t
v
es
se
ls
fo
r
au
to
lo
g
o
u
s
b
re
as
t
re
co
n
st
ru
ct
io
n
V
es
se
l
A
d
v
an
ta
g
es
D
is
ad
v
an
ta
g
es
In
te
rn
al
m
am
m
ar
y
ar
te
ry
E
li
m
in
at
es
th
e
n
ee
d
fo
r
ax
il
la
ry
d
is
se
ct
io
n
an
d
p
o
te
n
ti
al
ri
sk
o
f
ly
m
p
h
o
ed
em
a
an
d
n
er
v
e
d
am
ag
e
[9
].
R
es
p
ir
at
o
ry
m
o
v
em
en
t.
L
ar
g
er
d
ia
m
et
er
an
d
su
p
er
io
r
fl
o
w
co
m
p
ar
ed
w
it
h
th
e
th
o
ra
co
d
o
rs
al
v
es
se
ls
[9
,
1
1
2
].
R
is
k
o
f
p
n
eu
m
o
th
o
ra
x
an
d
p
o
st
-o
p
er
at
iv
e
p
u
lm
o
n
ar
y
co
m
p
li
ca
ti
o
n
s
[4
,
9
,
1
4
,
3
2
,
1
1
3
].
C
o
n
si
st
en
t
lo
ca
ti
o
n
th
at
is
ea
sy
to
ac
ce
ss
th
ro
u
g
h
m
ic
ro
su
rg
ic
al
m
ea
n
s.
G
o
o
d
p
o
si
ti
o
n
in
g
fo
r
su
rg
eo
n
an
d
as
si
st
an
t
[1
4
,
1
1
3
,
1
1
4
].
N
ee
d
fo
r
ri
b
re
se
ct
io
n
m
ay
ca
u
se
co
n
to
u
r
d
ef
o
rm
it
ie
s
an
d
p
o
st
-
o
p
er
at
iv
e
p
ai
n
al
th
o
u
g
h
th
is
ca
n
b
e
av
o
id
ed
th
ro
u
g
h
an
in
te
rc
o
st
al
ap
p
ro
ac
h
to
ac
ce
ss
in
g
th
e
IM
A
s
[9
,
1
4
,
3
1
,
9
9
,
1
1
8
].
O
th
er
m
in
im
al
ly
in
v
as
iv
e
ap
p
ro
ac
h
es
h
av
e
al
so
b
ee
n
d
es
cr
ib
ed
[8
2
].
R
eq
u
ir
es
a
sh
o
rt
er
p
ed
ic
le
th
an
ax
il
la
ry
v
es
se
ls
fo
r
an
as
to
m
o
si
s
[1
4
,
1
1
5
].
P
re
cl
u
d
es
fu
tu
re
C
A
B
G
w
it
h
IM
A
s
[1
4
,
1
5
].
M
ed
ia
l
lo
ca
ti
o
n
o
f
v
es
se
ls
al
lo
w
s
fo
r
m
o
re
fl
ex
ib
le
fl
ap
p
la
ce
m
en
t
an
d
su
p
er
io
r
sh
ap
in
g
o
f
th
e
b
re
as
t
m
o
u
n
d
,
es
p
ec
ia
ll
y
w
it
h
sm
al
le
r
fl
ap
s
[1
4
,
1
1
3
,
1
1
5
–
1
1
7
].
T
h
o
ra
co
d
o
rs
al
ar
te
ry
E
as
y
ac
ce
ss
in
p
at
ie
n
ts
w
h
o
ar
e
u
n
d
er
g
o
in
g
ax
il
la
ry
ly
m
p
h
ad
en
ec
to
m
y
as
th
e
ax
il
la
is
al
re
ad
y
ex
p
o
se
d
[1
4
].
P
ri
m
ar
y
ax
il
la
ry
d
is
se
ct
io
n
fo
r
b
re
as
t
ca
n
ce
r
is
b
ec
o
m
in
g
le
ss
co
m
m
o
n
b
ec
au
se
o
f
th
e
in
cr
ea
si
n
g
u
se
o
f
se
n
ti
n
el
ly
m
p
h
n
o
d
e
b
io
p
sy
.
A
d
d
it
io
n
al
d
is
se
ct
io
n
s
ar
e
to
ex
p
o
se
th
e
th
o
ra
co
d
o
rs
al
v
es
se
ls
in
th
es
e
ca
se
s
[1
4
].
C
o
n
si
st
en
t
an
at
o
m
y
an
d
ad
eq
u
at
e
d
ia
m
et
er
,
es
p
ec
ia
ll
y
at
th
e
le
v
el
o
f
th
e
se
rr
at
u
s
b
ra
n
ch
[1
4
,
1
1
9
].
T
h
o
ra
co
d
o
rs
al
v
es
se
ls
ar
e
fr
eq
u
en
tl
y
d
am
ag
ed
b
y
ax
il
la
ry
ly
m
p
h
n
o
d
e
cl
ea
ra
n
ce
an
d
p
o
st
-o
p
er
at
iv
e
ra
d
io
th
er
ap
y
m
ak
in
g
th
em
su
b
o
p
ti
m
al
fo
r
d
el
ay
ed
re
co
n
st
ru
ct
io
n
s
w
h
er
e
th
e
in
ci
d
en
ce
o
f
u
n
u
sa
b
le
v
es
se
ls
an
d
fl
ap
lo
ss
ar
e
1
1
an
d
6
%
,
re
sp
ec
ti
v
el
y
[1
4
,
1
1
2
,
1
1
5
,
1
1
9
].
C
o
m
m
o
n
ly
u
se
d
re
ci
p
ie
n
t
v
es
se
l
w
it
h
p
ro
v
en
re
li
ab
il
it
y
[1
4
,
8
3
,
1
1
6
,
1
2
0
,
1
2
1
].
D
o
es
n
o
t
p
re
cl
u
d
e
fu
tu
re
C
A
B
G
.
L
im
it
s
th
e
o
p
ti
o
n
s
fo
r
re
-o
p
er
at
iv
e
b
re
as
t
re
co
n
st
ru
ct
io
n
if
th
e
o
ri
g
in
al
fl
ap
fa
il
s
o
r
tu
m
o
u
r
re
cu
r
as
th
e
p
ed
ic
le
d
la
ti
ss
im
u
s
d
o
rs
i
an
d
th
o
ra
co
d
o
rs
al
ar
te
ry
p
er
fo
ra
to
r
fl
ap
s
ar
e
al
so
b
as
ed
o
ff
th
e
th
o
ra
co
d
o
rs
al
v
es
se
ls
[1
0
,
1
4
].
P
at
ie
n
t
p
o
si
ti
o
n
re
q
u
ir
ed
fo
r
m
ic
ro
an
as
to
m
o
si
s
is
d
if
fi
cu
lt
fo
r
th
e
as
si
st
an
t,
re
q
u
ir
in
g
th
em
to
re
ac
h
ac
ro
ss
th
e
ch
es
t
[1
0
,
1
4
,
1
1
4
].
A
es
th
et
ic
al
ly
in
fe
ri
o
r
to
th
e
IM
A
as
th
ey
m
ay
re
su
lt
in
u
n
n
at
u
ra
ll
y
la
te
ra
l
fl
ap
p
la
ce
m
en
t
an
d
ax
il
la
ry
sc
ar
ri
n
g
[1
1
4
].
R
is
k
o
f
p
ed
ic
le
av
u
ls
io
n
an
d
sh
o
u
ld
er
st
if
fn
es
s
b
ec
au
se
o
f
im
m
o
b
il
is
at
io
n
[1
3
,
3
1
].
C
ir
cu
m
fl
ex
sc
ap
u
la
r
ar
te
ry
L
ar
g
e
ar
te
ri
al
an
d
v
en
o
u
s
d
ia
m
et
er
s
(1
.5
–
3
m
m
)
ar
e
fa
v
o
u
ra
b
le
fo
r
m
ic
ro
an
as
ta
m
o
si
s
to
th
e
D
IE
P
p
ed
ic
le
[1
2
1
].
P
at
ie
n
t
p
o
si
ti
o
n
re
q
u
ir
ed
fo
r
m
ic
ro
an
as
to
m
o
si
s
is
d
if
fi
cu
lt
fo
r
th
e
as
si
st
an
t,
re
q
u
ir
in
g
th
em
to
re
ac
h
ac
ro
ss
th
e
ch
es
t
[1
4
,
1
1
4
].
R
ar
el
y
d
am
ag
ed
b
y
p
re
v
io
u
s
su
rg
er
y
o
r
ir
ra
d
ia
ti
o
n
[1
4
,
1
2
1
].
M
ed
ia
l
p
la
ce
m
en
t
o
f
th
e
b
re
as
t
m
o
u
n
d
w
as
re
st
ri
ct
ed
,
an
d
la
te
ra
l
fu
ll
n
es
s
o
f
th
e
fl
ap
w
as
a
co
m
m
o
n
p
ro
b
le
m
[1
1
4
].
D
o
es
n
o
t
p
re
cl
u
d
e
fu
tu
re
C
A
B
G
.
184 Breast Cancer Res Treat (2012) 134:181–198
123
Despite the evolution of drug-eluting stents, studies show
that CABG is still preferred in the management of three-
vessel disease and left-anterior descending (LAD) as it is
associated with lower rates of mortality, myocardial infarc-
tion and repeat revascularisation [34]. In 2010, 64.2 CABGs
were performed per 100,000 people in OECD countries, one
in three of which were in women [18, 35] (Table 1).
Currently, the IMAs are the gold standard CABG conduits
in terms of graft patency and patient survival [36–38] (see
Table 3). Unlike other arterial conduits, the IMAs appear to
be immune to atherosclerosis, vasospasm and endothelial
injury [38–40]. This is hypothesized to be because of the
IMA’s demonstrably higher rates of apoptosis, superoxide
dehydrogenase activity and nitric oxide production, which
allow it to actively dilate and remodel favourably in response
to increases in blood flow [39, 41–43]. Overall, the left IMA
(LIMA) has a patency rate of 85–92% at 15 years when
grafted to the LAD [38, 44, 45] compared with around 53%
for saphenous vein grafts [38, 46]. The right IMA (RIMA)
demonstrates identical patency rates to the LIMA when
grafted to the LAD, although this appears diminishes when
grafted to a non-left-sided vessel [38]. Recent reports,
however, suggest that the observed inferiority of the RIMA
compared with the LIMA is likely to be because of technical
factors rather than the biology of the RIMA itself [47].
At present, more than 90% of CABGs performed in the
United States use at least one IMA, most commonly LIMA-
LAD [37, 47, 48]. However, there is emerging evidence that
the use of two IMAs in bilateral grafting (BIMA) may be
superior to and supersede single IMA grafting as the gold
standard procedure [38, 41, 49–58]. If this is the case, then
there is an even greater imperative to preserve both IMAs.
Definitive results from these trials, however, will not be
available for several years [38, 41, 54]. Preserving the IMAs
for future CABG is especially important to breast cancer
patients as they are at an increased risk for coronary artery
disease [59–61]. In fact, coronary heart disease is the main
cause of non-cancer-related mortality in breast cancer patients
treated with adjuvant radiotherapy. When followed up over the
longer term, breast cancer patients receiving radiation, espe-
cially to the left side, are 1.0–2.2 times more likely to suffer a
fatal cardiovascular event [10, 59–62]. This statistic is par-
ticularly worrisome as according to the TEAM trial, 38.8%
mastectomy patients receive adjuvant radiotherapy worldwide
[20]. Unfortunately, the exact magnitude of this dilemma
remains elusive as there are no reliable means of estimating the
precise number of women affected. On the conservative side,
one retrospective study only reported an incidence of 0.8%
(n = 120:1) for the two conditions occurring in the same
patient [9]. In contrast, others have suggested that the number
needed to treat to save one IMA for CABG is 61:1 and that the
average surgeon can be expected to preserve 12 IMAs during
their career [10, 13]. Yet another author reported 81 cases ofT
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perioperative myocardial infarctions following breast recon-
structions during a 4-year period [63]. Ultimately, these esti-
mates are highly variable and possibly understate the true
extent of this predicament as the peak incidences of the two
diseases occur up to two decades apart and are thus not
captured by existing studies (Fig. 2). Furthermore, selection
biases exist in single-operator audits, and retrospective studies
may not account for the women who choose not to receive one
procedure over concerns of the other.
Since the introduction of DIEP flaps, more knowledge has
come to light on its long-term survival with regard to its ped-
icle. A number of animal studies and case reports suggest that
DIEP flaps can survive after separation from the IMA pedicle
7–9 days post-operatively [15, 64–68] if there is a cutaneous
inset. Therefore, if the IMAs anastomosed to the DIEP pedicles
are long enough to reach the coronary arteries, they can theo-
retically be disconnected from the DIEP flap and manoeuvred
back into the thoracic cavity to be reused in CABG as needed.
To test the feasibility of this theory, we conducted an
anatomical study comparing the lengths of the IMAs at every
ICS against empirical measurements of IMA length required
for grafting to the LAD as reported in the literature. We
hypothesise that knowledge of the IMA length at any given
level of dissection may allow us to modify the way in which
DIEPs are performed to preserve a sufficient length of IMA to
be reused for future CABG. As a secondary objective, we
summarise in the discussion a review of alternative techniques
for DIEP reconstruction. From this, we explore a range of other
approaches to spare the IMA to provide a comprehensive
review of possible solutions to the current dilemma.
Method
Anatomical study
A combined cadaveric and clinical anatomical study of 315
hemi-thoracic walls was undertaken following ethics
committee approval. Specimens and patients were females
of mixed body habitus with mean ages of 82 years
(60–98 years) for the cadaveric study and 52 years
(30–75 years) for the clinical. The cadaveric study com-
posed of 75 cadaveric hemi-thoracic walls from 39 cadavers
(72 bilateral and 3 unilateral). In each case, plain X-ray
angiography of the IMA was undertaken through a well-
established technique of direct catheterization and injection
with a radio-opaque lead oxide injectant [69] (Fig. 3).
In the clinical study, preoperative imaging was performed
in 120 consenting patients before undergoing autologous
breast reconstruction. Of these, 42 patients underwent
computed-tomographic angiography (CTA) and 78 patients
colour duplex ultrasound (Fig. 4). Arterial phase CTA scans
were undertaken with intravenous contrast in all cases and
composed of non-ionic iodinated contrast media: Ultravist
370 (Schering, Berlin, Germany) or Omnipaque 350
(Amersham Health, Princeton, USA). Intravenous access
was obtained through an antecubital vein with an 18-gauge
cannula, and injections were performed with a biphasic
power injection pump at a flow rate of 4–6 ml/s. Image
reformatting was achieved with either Siemens Syngo In-
Space (Siemens, InSpace2004A_PRE_19) or Osirix (OsiriX
Medical Imaging Software, GPL Licensing Open Source
Initiative). For duplex ultrasound, a flow value was assigned
to the pulsatile arterial flow to accurately identify the IMA.
The key anatomical features measured were the IMA length
and diameter at each ICS. The origin of the IMA was measured
from the inferior aspect of the clavicle for consistency. The first
ICS was defined as the distance between the inferior aspect of
the clavicle to the superior aspect of the second rib. Each sub-
sequent ICS was defined as the space between the superior
aspects of adjacent ribs (Fig. 3). The length of each IMA was
measured to its bifurcation into its terminal branches, the deep
superior epigastric artery (DSEA) and the musculo-phrenic
Fig. 3 X-ray angiogram of the internal mammary arteries (IMAs) at
each intercostals space, illustrating the course of the IMA and the
reference points from which diameters and lengths were measured.
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Fig. 2 Incidence of coronary artery bypass grafts and breast recon-
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is a 20-year delay in the peak incidence between the two procedures
Breast Cancer Res Treat (2012) 134:181–198 187
123
artery. In addition, the presence and diameter of IMA perfo-
rators (IMAP) were recorded at each ICS.
In the cadaveric study, lengths were measured using a
vernier caliper, and vessel diameters were measured with a
0.1-mm-scaled glass slide and a 910 stereo microscope
(Leica M80 10X/23B). In the clinical study, both length
and vessel diameters were measured with the aforemen-
tioned software on thin slices with contrast-filled vessels
used to highlight internal vessel diameters.
Literature review
The length of IMA needed for CABG was determined
through searches of Medline, Pubmed and references from
relevant articles using the following terms:
• Coronary artery bypass grafting/CABG
• Internal mammary/thoracic artery
• IMA/LIMA/RIMA
• ITA/LITA/RITA
• Length/cm/mm/pedicle
• Needed/required/used/measured/harvested
• Left-anterior descending/LAD
The articles were then manually screened for empirical
measurements of the IMA lengths used in in situ grafting to
the LAD through median sternotomy or minimally invasive
techniques. Non-specific measurements of the IMA, free-
grafts and re-operative CABGs were excluded as were non-
English and duplicate references. In total, more than 500
references and 100 full text articles were reviewed.
To explore other solutions to this dilemma, similar
searches were conducted on the anatomy and clinical
application of the IMAs in autologous breast reconstruc-
tion and CABG. The results identified were manually
reviewed and selected based on their relevance to the
present topic.
Fig. 4 Internal mammary arteries as seen by computed-tomographic
angiography
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Results
Anatomical study
Measurements of the IMAs at each ICS from the 315 hemi-
thoracic walls are shown in Table 4. On average, the
RIMA (177.80 ± 44.3 mm) was shorter than the LIMA
(186.90 ± 37.5 mm), and bifurcated at a higher level.
Specifically, 26% of RIMAs measured bifurcated at the
fifth ICS and the rest at the level of the sixth rib. In con-
trast, 16% of the LIMAs bifurcated at the fifth ICS, 73% in
the sixth ICS and 11% in the seventh ICS.
The IMA diameter at each ICS progressively decreased
as the IMA descended caudally and exhibited little differ-
ence between each side (Table 4). The mean diameters of
the LIMA and RIMA were 2.8/2.8 mm (2.1–3.6 mm) at the
inferior border of the clavicle and 1.7/1.8 mm at the
bifurcation.
The size and number of IMAPs exhibited a similar
pattern, decreasing from an average size of 1.4–1.5 mm in
the first two ICS to 0.6–0.9 cm in the lower three ICS’
(Table 5). The presence of perforators[1 mm was present
in 87 and 91% of patients in the first two ICS, but only 3%
by the sixth ICS.
Literature review
From the review on the IMAs, 11 studies quoted exact
lengths of the LIMA needed to graft the LAD and are
shown in Table 6 [70–81]. Of these, five used open har-
vesting techniques (n = 1,019) and six employed mini-
mally invasive techniques (n = 555). The mean lengths
weighted according to sample size were 160.08 and
152.70 mm, respectively, and correspond anatomically to
the level of the fourth rib.
The exact length of the RIMA required for CABG was
inconsistently reported as it depended to a large degree on
the arteries bypassed and type of anastomosis used. The
bulk of the literature that we reviewed harvested the RIMA
from its bifurcation (177.80 mm in our study) and trimmed
it to the required length intraoperatively. For the purposes
of discussion, we use this more conservative figure to err
on the side of safety. Furthermore, we discuss the DIEP
pedicle, IMA perforators and the retrograde limb of the
Table 4 Anatomical features of the internal mammary arteries with lengths and diameters measured at each intercostal space
Right Left
Length (mm) Diameter (mm) Length (mm) Diameter (mm)
Mean Range Mean Range Length Range Mean Range
Origin – – 2.8 2.1–3.6 – – 2.8 2.2–3.5
First ICS 54.9 44–69 2.6 2.1–3.2 58.7 42–74 2.6 2.0–3.2
Second ICS 88.1 75–118 2.4 1.6–3.1 92.9 72–119 2.4 1.7–3.1
Third ICS 119.1 100–156 2.1 1.4–2.8 121.1 101–156 2.1 1.5–2.8
Fourth ICS 148.5 120–188 1.9 1.3–2.5 148.9 121–190 2 1.2–2.6
Fifth ICS 170.8 142–210 1.8 1.2–2.4 167.1 139–208 1.8 1.2–2.5
Sixth ICS – – – – 182.1 161–202 1.7 1.4–2.5
Bifurcation 177.8 132–233 1.8 1.1–2.3 186.9 150–225 1.7 1.0–2.5
Table 5 Presence and diameter
of internal mammary artery
perforators at each intercostal
space
Right Left
Presence
of perforating
branch of the
IMA [ 1 mm
in diameter (%)
Perforator diameter (mm) Presence
of perforating
branch of the
IMA [ 1 mm
in diameter (%)
Perforator diameter (mm)
Mean Range Mean Range
First ICS 87 1.4 0.8–2.1 88 1.4 0.8–2.5
Second ICS 91 1.5 0.9–2.5 92 1.6 0.9–2.9
Third ICS 65 0.9 0.5–1.8 70 0.9 0.5–2.8
Fourth ICS 6 0.6 0.3–1.5 13 0.6 0.3–1.4
Fifth ICS 5 0.6 0.3–1.3 9 0.6 0.3–1.0
Sixth ICS3 – – – 3 0.5 0.3–1.0
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IMA as the most relevant and novel approaches of using
the IMA for DIEP flaps and CABGs.
Discussion
Comparing the anatomical features of the in situ IMAs at
each ICS will assist in bridging an elusive gap between
reconstructive and cardiothoracic techniques. Based on the
results of our study and literature review, there are five
methods of modifying the DIEP to allow future reuse of
IMA for CABG.
Technique 1: lowering the site of DIEP anastomosis
Our anatomical study (Table 4) shows the ICS’ at which
DIEP reconstructions can be safely performed to preserve
these IMA lengths for pedicled grafting to be the fifth for
the left and sixth on the right. If the IMAs are harvested in
a skeletonised fashion, the additional length gained permits
DIEP reconstructions to be anastomosed one level higher
in the fourth and fifth ICS’ (Fig. 5). These conclusions
correlate well with the only other study on this technique
which also supports the fourth and fifth ICS as being
suitable for leaving a sufficient length of IMA for future
CABG [15]. Some surgeons have raised concerns regarding
the diameter of the IMA below the fourth ICS and that the
fifth to seventh costal cartilages are very narrow and
sometimes fused. Our study indicated that the mean
diameter of the LIMA was 2.0 mm (1.2–2.6) at the fourth
ICS that is sufficient for an end-to-end anastomosis. The
RIMA was also of sufficient calibre, averaging 1.8 mm
(1.2–2.4) at the fifth ICS. A standard rib resection or
minimally invasive approach can be used to access the
IMA should the interspaces be narrow [82].
The main limitation of this technique is the relative
inconsistency of the internal mammary vein (IMV) below
the third ICS. The IMVs are almost universally present and
accompany the IMA as they descend caudally lateral to the
sternum. However, around 70% of IMVs (types 1 and 3)
bifurcate by the fourth rib to form two vessels of reduced
internal diameter [83]. Accordingly, there is a significant
degree of variability in the diameters available for anas-
tomosis at the fifth ICS (1.0–3.9 mm), creating a degree of
uncertainty regarding the availability of adequate venous
drainage at that level [83]. This is an understandable con-
cern to surgeons as venous congestion is a major cause of
flap failure, complicating up to 10% of conventional DIEP
reconstructions with up to 5% requiring reoperation
[84–87]. Fortunately, the majority of IMVs at this level are
of suitable calibre (1.7–2.5 mm) and can be accurately
assessed through radiological means. Although this tech-
nique may not be an option for every patient, suitable
candidates can be readily identified through careful pre-
operative imaging. If the IMVs are small, then it is
important to consider the superficial epigastric veins
(SIEVs) [84, 86, 88–90]. Flap congestion has been noted to
occur when the SIEV exceeds 1.5 mm in diameter as this
is postulated to be associated with inadequate venous
communication between the two systems [86, 91]. There-
fore, a popular solution for overcoming venous complica-
tions takes the form of routinely exposing the SIEV when
Table 6 Lengths of internal
mammary arteries required for
coronary artery bypass grafting
to the left-anterior descending
artery, as quoted in the literature
Study Year LIMA-LAD N
Median sternotomy
Calafiore et al. [70] 1998 161.00 14
177.00 14
Deja et al. [71] 1999 170.00 287
177.00 70
Calafiore et al. [72] 1999 164.00 304
Bonacchi et al. [57] 2005 142.00 310
Gwozdziewicz [75] 2008 166.90 20
Minimally invasive CABG (MICABG)
Boonstra et al. [76] 1997 140.00 20
Lazarra et al. [77] 1999 153.00 16
143.00 10
Zenati et al. [78] 1999 150.00 27
Cremer et al. [79] 1999 150.00 205
Trehan et al. [80] 2000 156.00 267
Ishikawa et al. [81] 2007 162.00 10
Weighted average standard CABG 160.08 1,019
Weighted average MICABG 152.70 555
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raising the DIEP flap for either prophylactic creation of an
additional venous outflow or as a ‘lifeboat’ for salvaging
congested flaps in the post-operative period [84, 91–94].
The SIEV can then be anastomosed to augment the blood
flow from the superficial to deep systems to the DIEV or its
vena comitantes, or as an alternative outflow to other
venous networks such as the IMV (retrograde limb or
perforator vessels) [95, 96], lateral thoracic, thoracodorsal,
circumflex scapula, intercostal, cephalic or basilic veins.
Regardless of the choice of anastomosis, there is some
evidence that the use of an additional venous outflow
option can reduce the incidence of flap congestion without
affecting flap survival or operating time [84, 90].
Technique 2: using IMA perforators
Several studies have suggested that DIEP flaps can be
anastomosed to IMAPs to spare the IMA proper for future
use in CABG [9, 12–14, 31–33, 97, 98]. The additional
advantages of using IMAPs compared with the IMAs
include avoidance of the need to excise the ribs or costal
cartilage to gain access the IMA, and in doing so also
minimises operating time, post-operative pain, pulmonary
complications and contour deformities (Table 2) [13, 14,
31, 99, 100]. The disadvantages of IMAPs centre on con-
cerns over their reliability, availability, calibre and venous
drainage. These factors have limited the widespread uptake
of IMAP as recipient vessels, however, new studies are
now clarifying much of the uncertainty surrounding this
technique. Recent clinical series by Follmar et al. [13] and
Saint-Cyr et al. [32] have both shown that with careful
patient selection and adequate clinical experience, DIEP
flaps can be safely anastomosed to IMAPs without
increasing the incidence of flap loss or fat necrosis com-
pared with the IMA or thoracodorsal vessels. Several
studies, this study included, show that such a procedure is
anatomically feasible in the majority of women given the
high incidence of usable perforators in the first and second
ICS (87–91%) [12, 33]. Interesting however, the proportion
of breast reconstructions with suitable IMAPs reported
ranges from 9 to 39% depending on the institutional
selection criteria (Table 7) [12–14, 31, 32, 98]. A major
factor limiting the uptake of IMAPs is perforator damage
during mastectomy and/or radiotherapy. If the breast
surgeon is vigilant, this should not be a problem, and in
selected cases, a more proximal segment of the undamaged
IMA or an interspace spared radiation may be used [14,
32]. As with any new procedure, a learning curve exists
within the surgical unit and uptake rates increase with the
number of DIEP-IMAPs performed. A prospective study of
100 consecutive DIEP flaps clearly demonstrated increas-
ing IMAP rates with every 20 reconstructions performed,
as IMAP vessels were increasingly spared by the general
surgeons during mastectomy and used for subsequent
reconstruction. By the end of this study, an use rate of 45%
(n = 9/20) was achieved without a statistical increase in
the number of complications [13].
In terms of IMAP calibre, previous studies have
reported values of between 1.0 and 1.83 mm with the
largest or ‘principle’ perforator lying in the second or third
ICS (Tables 7 and 8) [12–14, 31–33, 101]. This is in
keeping with our findings that show the highest incidence
of usable perforators ([1 mm) to be in the second ICS
(91%) with a mean internal diameter of 1.5 mm
(0.9–2.5 mm) on the right IMA and 1.6 mm (0.9–2.9 mm)
on the left. Any mismatch between the DIEP pedicle and
the IMAP can be overcome through traditional microsur-
gical techniques. Our analysis of 315 hemi-thoracics is the
largest study to date and all measurements were accurate
to 0.1 mm.
Some authors have expressed concern over the venous
drainage of DIEP-IMAP reconstructions. Given the afore-
mentioned rates of venous complications in conventional
DIEP flaps, it is understandable, therefore, to assume that
DIEP-IMAP flaps may experience at least an equivalent if
not higher rate of venous inadequacy given the smaller
calibre of perforator vessels. However, this does not appear
Fig. 5 Technique 1: lowering the site of DIEP anastomosis. A deep
inferior epigastric artery perforator flap that is anastomosed at the fifth
intercostal space leaves a sufficient length of the internal mammary
artery for direct reuse in coronary artery bypass grafting
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to be the case in the studies to date and intra-operative
measurements by Saint-Cyr et al. found that IMV and IMVP
have similar diameters (2.8 vs. 2.9 mm) after reversing
vessel spasm and mechanical dilation [32]. Furthermore,
DIEP-IMAP flaps can be supercharged with additional
venous outflows as described in Technique 1.
Using our review of the cardiothoracic literature, we
propose two ways in which a ‘DIEP-IMAP’ flap can be
performed to preserve the IMA for CABG. First, it may be
possible to separate the IMAP from its parent vessel after a
period of delay in the process of skeletonising the IMA for
CABG (Fig. 6a). The advantage of this method is that it
enables IMAs to be harvested through a standard cardio-
thoracic technique without a need for increased operating
time. Alternatively, the LIMA may be harvested without
disconnecting the DIEP-IMAP (Fig. 6b) by skeletonising
the LIMA from the level of the flap, beyond its bifurcation,
to the first 2–3 cm of the DSEA, a technique similar to
harvesting an extended RIMA for grafting to non-LAD
arteries. This method may permit both the DIEP and LAD
to be perfused with the same IMA.
Technique 3: end-to-side anastomosis of the DIEP flap
to the IMA
End-to-side arterial anastomosis is a well-described tech-
nique in microsurgical free flap reconstructions and has
been shown to be as consistent and reliable as traditional
end-to-end anastomosis in both clinical and experimental
studies [10, 11, 102–107]. A recent series by Apostolides
et al. comparing 15 end-to-side anastomosis with and
equivalent number of end-to-end anastomosis in 30 con-
secutive DIEP and SIEA reconstructions demonstrated that
the only statistically significant difference between the two
techniques was longer ischemia in the end-to-side group
(20 min) [10]. These were not associated with increased
flap complications or the no-reflow phenomenon.
Technique 4: using the DIEP pedicle as a composite
graft
Recent studies have shown that the average DIEP pedicle
processes a similar diameter to the IMA (2.0–3.6 vs.
Table 7 Clinical studies that have used the internal mammary artery perforators as recipient vessels in autologous breast reconstruction as a
means of sparing the internal mammary artery for coronary artery bypass grafting
Study Year n Suitable
cases (%)
Mean vessel diameter (mm) ICS used Flaps performed Flap
necrosis
(%)
Follow up
(months)
Hamdi et al. [14] 2003 30 9.0 Artery = 1.0 (0.5–1.3) Second = 30% DIEP = 26 3.3 1–26
Vein = 1.7 (1.0–3.0) Third = 70% SGAP = 3
SIEA = 1
Hayward et al. [125] 2003 21 39.0 – Second and third DIEP, SGAP, SIEA 0 –
Park et al. [98] 2003 5 – Artery = 1.56 (1.2–2.5) – TRAM 20 6–14
Vein = 1.4 (1.0–2.2) –
Munhoz et al. [12] 2004 40 32.5 – – DIEP = 38 0 –
Saint-Cyr et al. [32] 2007 38 27.0 Artery = 1.9 (1.5–2.0) Second = 41% MS-TRAM = 12 1 –
Vein = 2.9 (1.7–4.0) Third = 53% DIEP = 10
Fourth = 6% TRAM = 9
SIEA = 7
Follmar et al. [13] 2008 23 23 – – DIEP = 23 4 0.25–46.75
Table 8 Anatomical studies
that have investigated the
presence and diameter of
internal mammary artery
perforators for the purpose of
assessing its suitability as a
recipient vessel in autologous
breast reconstruction
Study Year n IMAP present
in second
or third ICS (%)
Mean vessel diameter (mm)
Park et al. [98] 2003 5 – Artery = 1.56 (1.2–2.5)
Vein = 1.4 (1.0–2.2)
Munhoz et al. [12] 2004 32 86 Artery = 0.85 (0.6–1.0)
Rosson et al. [101] 2005 20 – Artery = 1.14 (0.3–2.7)
Vein = 1.14 (0.25–3.5)
Schmidt et al. [33] 2008 20 95 Artery = 1.3 (0.4–2.9)
This study 2011 315 91 Artery = 1.27 (0.3–2.5)
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1.7–2.8 mm) [108]. Therefore, if a CABG is necessary, a
segment of the DIEP pedicle can be used as a composite
graft to obtain the length required (Fig. 7). In fact, the
DIEP’s parent vessel, the inferior epigastric artery, has
been used as a composite graft with excellent patency rates
(85% during 81 months), possibly because of the
downstream effect of cytokine secretion by the IMAs [38,
109]. The advantage of this method is that it enables
women with pre-existing DIEP flaps to receive IMA-based
CABGs if needed. To facilitate this, reconstructive
surgeons should aim to harvest the DIEP in its entirety
(8–15 cm) and tunnel the pedicle to the anastomotic site to
Fig. 6 Technique 2: using IMA perforators. Two methods of
performing coronary artery bypass grafting options for a deep inferior
epigastric artery perforator (DIEP) flap that is anastomosed to the
internal mammary artery perforators at the second intercostal space.
a Shows the separation of the DIEP flap during harvesting of the
internal mammary artery. b Shows the DIEP flap left in situ for shared
perfusion with the left-anterior descending artery
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minimise handling of the IMA [108]. Most patients with
pre-existing DIEP flaps are amenable to this technique and
the patency of the DIEP pedicle can be imaged pre-oper-
atively to assess patency and flow rates before CABG.
Technique 5: the retrograde DIEP flap
Retrograde flow from the distal limb of the IMAs has
been used on rare occasions for CABG and salvage of
breast reconstructions with compromised arterial supply [110,
111]. Historically, studies from the 1980s intra-operatively
measured the retrograde flow from the distal IMA to be as high
as 60 ml/min [110]. Retrograde CABGs, however, did not
become mainstream because of the unpredictable and highly
variable vascular anatomy between individuals. Now,
advances in imaging technology enable surgeons to accurately
visualise anatomical variations. Therefore, we hypothesise
that under the guidance of careful preoperative imaging, a
‘retrograde DIEP’ flap anastomosed to the distal IMA may be
a feasible recipient vessel for DIEP flaps in select individuals
(Fig. 8), especially as the distal limbs of the IMV have also
been used successfully as an outflow option for DIEP flaps.
The ‘retrograde DIEP flap’ is untested although personal
experience of some surgeons suggest that the technique of
anastomosing the DIEP flap in a retrograde fashion is not
always predictable and often requires a need to maintain a
mean systolic pressure of above 130 mmHg; and is there-
fore a suboptimal strategy in women with strong cardio-
vascular risk factors. Nonetheless, further investigations
are warranted as this approach may preserve the operative
field entirely undisturbed for future CABG. Further and
importantly, the metabolic requirements needed to support
a DIEP flap are unlikely to be as demanding as those of a
coronary artery to which the distal IMA has already been
successfully grafted.
Impact of findings
The findings of this study support the theory that using the
IMA for autologous breast reconstruction is not an absolute
contraindication for CABG as there are a number of pro-
cedures that can be used to accommodate high-risk
patients. The optimal techniques for reconstruction
following mastectomy and coronary artery bypass grafting
are not necessarily mutually exclusive and affects two
major patient populations: women who require recon-
struction after bilateral mastectomy (10% and growing)
Fig. 7 Technique 4: using the DIEP pedicle as a composite graft. The
deep inferior epigastric artery perforator (DIEP) pedicle can be used
to extend the internal mammary artery for coronary artery bypass
grafting in patients with conventional DIEP flaps anastomosed at the
third intercostal space
Fig. 8 Technique 5: the retrograde DIEP flap. A deep inferior
epigastric artery perforator flap that is anastomosed to the retrograde
limb of the internal mammary artery (IMA), leaving the proximal
IMA undisturbed for coronary artery bypass grafting
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and women who derive a survival benefit from BIMA that,
pending results of current trials, may be the majority of
CABG candidates. The full impact of these findings is
likely to be under-appreciated because of the age gap
between the two conditions (Fig. 2), the projected increase
in both conditions and the fact that current statistics on
breast reconstruction exclude women turned away from
DIEP flaps for fear of its prohibitive effect on future heart
surgery. The concepts brought forward in this study aim to
catalyse further discussion and collaboration between car-
diothoracic surgeons and plastic surgeons, to potentially
improve women’s health.
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